AI Summary
✦ ClarthaAether Industries is a specialty chemicals manufacturer producing advanced intermediates for pharmaceutical, agrochemical, and materials-science customers. Large-scale manufacturing, contract research and manufacturing, and contract or exclusive manufacturing services drive revenue, alongside exports. June 2026 consolidated sales rose 27.5% year-on-year to ₹326.6 crore, supporting operating leverage as margins improve. ROE is unavailable, while improving margins and 38.5% profit growth indicate favorable earnings momentum. Debt-to-equity of 18.65x implies severe leverage, which can materially inflate reported ROE and increase financial risk. At 89.3x earnings, the stock appears rich relative to 38% growth, leaving limited room for execution setbacks. The key question is whether capacity expansion and the Dow-linked silicone technology collaboration can sustain growth without weakening cash generation.
Price Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
From 6 analysts
Fundamentals
Fundamentals institutional score is 80 using growth durability 79.8.
Valuation
Valuation institutional score is 12 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
Analyst View institutional score is 28 using mean target upside -7.3%; dispersion penalty 17.8; recommendation breadth from available consensus.
Technical Structure
Technicals institutional score is 45 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
Recent news flow is balanced or not decisive enough to tilt the tape. Based on 11 recent ticker-linked news items.
Signal Summary
Market intelligence remains Mixed. fundamentals provide support, while valuation and analyst consensus remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 82.9% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +4.22). Confidence: 82%.
Live forward EPS implies next-12-month EPS of ₹28.57. Applying the stock's normalized valuation corridor produces a fair range of ₹1,311.93 to ₹1,548.21, with base value near ₹1,394.22 (-12.7% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹28.57
Forward P/E
55.9x
Base Fair Value
₹1,394.22
Fair Range
₹1,311.93 - ₹1,548.21
Upside To Base
-12.7%
Estimate Source
Live forward EPS
Growth Estimate
+34.1%
5Y Average
51.94
Current
89.27
Overvalued
54.19
Undervalued
45.92
5Y Average
32.39
Current
55.87
Overvalued
33.43
Undervalued
29.08
5Y Average
5.54
Current
8.63
Overvalued
6.01
Undervalued
4.56
Peers & Comparison
Sector: Materials · Theme: Specialty Chemicals
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
SUPREME PETROCHEM LIMITED SPLPETROSpecialty Chemicals | +23.7% | 8.5% | 26.9x Undervalued | -37% vs avg | -4.3% |
ANUPAM RASAYAN INDIA LTD ANURASSpecialty Chemicals | +27.5% | 7.2% | 78.8x Premium | +85% vs avg | +6.7% |
NAVIN FLUORINE INT. LTD NAVINFLUORSpecialty Chemicals | +44.1% | 21.7% | 53.0x Premium | +24% vs avg | +71.4% |
FINE ORGANIC IND. LTD. FINEORGSpecialty Chemicals | +22.1% | 17.8% | 36.9x Fair | -14% vs avg | +5.6% |
JUBILANT INGREVIA LIMITED JUBLINGREASpecialty Chemicals | +25.3% | 6.6% | 38.1x Fair | -11% vs avg | +6.3% |
ALKYL AMINES CHEM. LTD ALKYLAMINESpecialty Chemicals | -4.6% | 11.8% | 43.6x Fair | +2% vs avg | -9.0% |
CLEAN SCIENCE & TECH LTD CLEANSpecialty Chemicals | +10.5% | 23.7% | 36.6x Fair | -14% vs avg | -32.3% |
GALAXY SURFACTANTS LTD GALAXYSURFSpecialty Chemicals | +14.8% | 5.1% | 27.6x Undervalued | -35% vs avg | -14.4% |
AETHER INDUSTRIES LIMITED trades at a premium (89.6x vs peer avg 42.7x), implying higher growth or quality expectations from the Specialty Chemicals cohort. Peers include SUPREME PETROCHEM LIMITED, ANUPAM RASAYAN INDIA LTD, NAVIN FLUORINE INT. LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹257 CrJun 2026Latest net profit
₹48 CrJun 2026Latest EPS
₹3.64Jun 2026Net margin
31.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 161 | 164 | 155 | 115 | 180 | 196 | 197 | 215 | 215 | 230 | 258 | 237 | 257 |
| Expenses + | 116 | 118 | 124 | 106 | 137 | 142 | 138 | 147 | 146 | 158 | 165 | 176 | 177 |
| Operating Profit | 45 | 46 | 31 | 9 | 43 | 55 | 60 | 67 | 69 | 72 | 92 | 62 | 80 |
| OPM % | 28% | 28% | 20% | 8% | 24% | 28% | 30% | 31% | 32% | 31% | 36% | 26% | 31% |
| Other Income + | 3 | 15 | 6 | 6 | 9 | 9 | 11 | 3 | 0 | 7 | -2 | 8 | 10 |
| Interest | 1 | 2 | 2 | 4 | 3 | 2 | 3 | 2 | 3 | 2 | 3 | 5 | 4 |
| Depreciation | 9 | 10 | 10 | 10 | 10 | 11 | 10 | 12 | 13 | 15 | 16 | 17 | 20 |
| Profit before tax | 37 | 50 | 25 | 2 | 40 | 52 | 57 | 56 | 53 | 62 | 72 | 49 | 66 |
| Tax % | 18% | 24% | 25% | 40% | 24% | 26% | 29% | 23% | 24% | 29% | 28% | 22% | 27% |
| Net Profit + | 30 | 38 | 19 | 1 | 30 | 38 | 41 | 43 | 40 | 44 | 52 | 38 | 48 |
| EPS in Rs | 2.28 | 2.85 | 1.44 | 0.08 | 2.28 | 2.87 | 3.08 | 3.24 | 3.03 | 3.29 | 3.92 | 2.86 | 3.64 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Announcement under Regulation 30 (LODR)-Press Release / Media Release